Genome Editing in Neurosciences

CHF 71.35
Auf Lager
SKU
FH3IIBA3O64
Stock 1 Verfügbar
Free Shipping Kostenloser Versand
Geliefert zwischen Mo., 27.10.2025 und Di., 28.10.2025

Details

This book is open access under a CC BY 4.0 license.

CRISPR-Cas9 is a rapid, efficient, versatile and relatively cheap method for dissecting the molecular pathways that are the basis of life, as well as for investigating and potentially rectifying faults in these pathways that result in disease.

This book reviews how CRISPR-Cas9 and other genome editing techniques are advancing our understanding of development and function in the nervous system, uncovering the molecular causes of neurological disorders and providing tools for gene therapy.


Highlights how genome editing is enabling breakthroughs in how we study the brain Identifies a powerful method to understand and treat central nervous system disorders Reveals system-level insight into how the nervous system develops and functions Includes supplementary material: sn.pub/extras

Autorentext
Rudolf Jaenisch, MIT Cambridge, USAFeng Zhang, MIT Cambridge, USAFred Gage, Salk Institute for Biological Studies, La Jolla, CA, USA

Klappentext

This book is open access under a CC BY 4.0 license.

Innovations in molecular biology are allowing neuroscientists to study the brain with unprecedented resolution, from the level of single molecules to integrated gene circuits. Chief among these innovations is the CRISPR-Cas genome editing technology, which has the precision and scalability to tackle the complexity of the brain. This Colloque Médecine et Recherche has brought together experts from around the world that are applying genome editing to address important challenges in neuroscience, including basic biology in model organisms that has the power to reveal systems-level insight into how the nervous system develops and functions as well as research focused on understanding and treating human neurological disorders.


Zusammenfassung

This book is open access under a CC BY 4.0 license.

CRISPR-Cas9 is a rapid, efficient, versatile and relatively cheap method for dissecting the molecular pathways that are the basis of life, as well as for investigating and potentially rectifying faults in these pathways that result in disease.

This book reviews how CRISPR-Cas9 and other genome editing techniques are advancing our understanding of development and function in the nervous system, uncovering the molecular causes of neurological disorders and providing tools for gene therapy.


Inhalt

Introduction.- In vitro modeling of complex neurological diseases.- Aquatic model organisms in neurosciences : the genome editing revolution.- Genome-wide genetic screening in the mammalian CNS.- CRISPR/Cas9-mediated Knockin and Knockout in Zebrafish.- Dissecting the role of synaptic proteins with CRISPR.- Recurrently Breaking Genes in Neural Progenitors: Potential Roles of DNA Breaks in Neuronal Function, Degeneration and Cancer.- Neuroscience research using non-human primate models and genome editing.- Multiscale genome engineering: Genome-wide screens and targeted approaches.- Using Genome Engineering to Understand Huntington's Disease.- Therapeutic gene editing in muscles and muscle stem cells.

Cart 30 Tage Rückgaberecht
Cart Garantie

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor Rudolf Jaenisch, Feng Zhang, Fred Gage
    • Titel Genome Editing in Neurosciences
    • Veröffentlichung 11.08.2018
    • ISBN 978-3-319-86801-1
    • Format Kartonierter Einband
    • EAN 9783319868011
    • Jahr 2018
    • Größe H235mm x B155mm
    • Untertitel Research and Perspectives in Neurosciences
    • Gewicht 221g
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 123
    • Herausgeber Springer, Berlin
    • GTIN 09783319868011

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.